Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William V Good

Showing results (91-100 of 99) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 99 results.
Archives of Ophthalmology (Chicago, Ill. : 1960)|April 14, 2010
Progression of type 2 to type 1 retinopathy of prematurity in the Early Treatment for Retinopathy of Prematurity StudyStephen P Christiansen, Velma Dobson, Graham E Quinn, et al.
Ophthalmology|January 8, 2011
Retinopathy of prematurity in infants weighing less than 500 grams at birth enrolled in the early treatment for retinopathy of prematurity studyDavid T Wheeler, Velma Dobson, Michael F Chiang, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association|February 5, 2025
Effect of bilirubin on visuocortical development in preterm infantsWilliam V Good, Ronald J Wong, Anthony M Norcia, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|November 15, 2006
Standard image of plus disease in retinopathy of prematurityAntonio Capone, Anna L Ells, Alistair R Fielder, et al.
Journal of AAPOS : the Official Publication of the American Association for Pediatric Ophthalmology and Strabismus|January 21, 2023
Ocular and developmental outcomes of a dosing study of bevacizumab for retinopathy of prematurityDavid K Wallace, Amra Hercinovic, Sharon F Freedman, et al.
JAMA Ophthalmology|April 24, 2020
Short-term Outcomes After Very Low-Dose Intravitreous Bevacizumab for Retinopathy of PrematurityDavid K Wallace, Raymond T Kraker, Sharon F Freedman, et al.
JAMA Ophthalmology|April 28, 2017
Assessment of Lower Doses of Intravitreous Bevacizumab for Retinopathy of Prematurity: A Phase 1 Dosing StudyDavid K Wallace, Raymond T Kraker, Sharon F Freedman, et al.
Ophthalmology|July 12, 2021
International Classification of Retinopathy of Prematurity, Third EditionMichael F Chiang, Graham E Quinn, Alistair R Fielder, et al.
Molecular Vision|June 1, 2006
Proceedings of the Third International Symposium on Retinopathy of Prematurity: an update on ROP from the lab to the nursery (November 2003, Anaheim, California)Gerard A Lutty, Tailoi Chan-Ling, Dale L Phelps, et al.
Pageof 10

Showing results (91-100 of 99) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 99 results.
Archives of Ophthalmology (Chicago, Ill. : 1960)|April 14, 2010
Progression of type 2 to type 1 retinopathy of prematurity in the Early Treatment for Retinopathy of Prematurity StudyStephen P Christiansen, Velma Dobson, Graham E Quinn, et al.
Ophthalmology|January 8, 2011
Retinopathy of prematurity in infants weighing less than 500 grams at birth enrolled in the early treatment for retinopathy of prematurity studyDavid T Wheeler, Velma Dobson, Michael F Chiang, et al.
Journal of Perinatology : Official Journal of the California Perinatal Association|February 5, 2025
Effect of bilirubin on visuocortical development in preterm infantsWilliam V Good, Ronald J Wong, Anthony M Norcia, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|November 15, 2006
Standard image of plus disease in retinopathy of prematurityAntonio Capone, Anna L Ells, Alistair R Fielder, et al.
Journal of AAPOS : the Official Publication of the American Association for Pediatric Ophthalmology and Strabismus|January 21, 2023
Ocular and developmental outcomes of a dosing study of bevacizumab for retinopathy of prematurityDavid K Wallace, Amra Hercinovic, Sharon F Freedman, et al.
JAMA Ophthalmology|April 24, 2020
Short-term Outcomes After Very Low-Dose Intravitreous Bevacizumab for Retinopathy of PrematurityDavid K Wallace, Raymond T Kraker, Sharon F Freedman, et al.
JAMA Ophthalmology|April 28, 2017
Assessment of Lower Doses of Intravitreous Bevacizumab for Retinopathy of Prematurity: A Phase 1 Dosing StudyDavid K Wallace, Raymond T Kraker, Sharon F Freedman, et al.
Ophthalmology|July 12, 2021
International Classification of Retinopathy of Prematurity, Third EditionMichael F Chiang, Graham E Quinn, Alistair R Fielder, et al.
Molecular Vision|June 1, 2006
Proceedings of the Third International Symposium on Retinopathy of Prematurity: an update on ROP from the lab to the nursery (November 2003, Anaheim, California)Gerard A Lutty, Tailoi Chan-Ling, Dale L Phelps, et al.
Pageof 10